Vit Vasista

2019

In 2019, Vit Vasista earned a total compensation of $2.2M as EVP, Chief Financial Officer at Regenxbio.

Compensation breakdown

Non-Equity Incentive Plan$180,395
Option Awards$1,548,133
Salary$439,988
Other$16,100
Total$2,184,616

Vasista received $1.5M in option awards, accounting for 71% of the total pay in 2019.

Vasista also received $180.4K in non-equity incentive plan, $440K in salary and $16.1K in other compensation.

Rankings

In 2019, Vit Vasista's compensation ranked 5,475th out of 13,971 executives tracked by ExecPay. In other words, Vasista earned more than 60.8% of executives.

ClassificationRankingPercentile
All
5,475
out of 13,971
61st
Division
Manufacturing
2,042
out of 5,695
64th
Major group
Chemicals And Allied Products
724
out of 2,194
67th
Industry group
Drugs
608
out of 1,880
68th
Industry
Biological Products, Except Diagnostic Substances
144
out of 389
63rd
Source: SEC filing on April 7, 2022.

Vasista's colleagues

We found four more compensation records of executives who worked with Vit Vasista at Regenxbio in 2019.

2019

Kenneth Mills

Regenxbio

Chief Executive Officer

2019

Olivier Danos

Regenxbio

Chief Scientific Officer

2019

Patrick Christmas

Regenxbio

Chief Legal Officer

2019

Curran Simpson

Regenxbio

EVP, Chief Operations and Technology Officer

News

In-depth

You may also like